Few drugs are major teratogens, but heightened vigilance is crucial to protect your pregnant patient. November 2007

In this group we will discuss all patient issues related to Reproductive Immunology. Topics will include, but are not limited to, immune related miscarriage, infertility, IVF failure, pregnancy complications and "unexplained' pregnancy loss. We work closely with research pioneer, Dr Alan E Beer. Our approaches are multiple: to share experiences, to offer support, to distribute the latest studies, to record information, to develop ongoing lists of helpful resources for the patient. In such spirit, all writing and documents can be shared. Web access to our group files at the Yahoo site strongly recommended. **Please note: Information in this group to be used for educational purposes only, not to substitute for medical advice. Please consult with your physician before undergoing any form of medical treatment.**

© 2000 - 2006 Preeclampsia Foundation

Kong 21 (2) 268 -- Nephrology Dialysis Transplantation

OBG Management, January 2007 · Vol. 19, No. 01. Despite extensive research on testing and prophylaxis, a cautious approach is warranted

Deborah K. Coon, R.Ph. Pharm. D. Candidate February 15, 2001

(c) 2008 American Family Physician. Provided by ProQuest Information and Learning. All rights Reserved.

Improved treatment means more women with all forms of arthritis have a better chance of having healthy babies. Jane Tadman reports.

We are a non-profit corporation whose mission is to raise awareness about the condition of HELLP Syndrome, raise money for research, provide support to families affected by this condition and conduct research on the condition.

Repromedix is a leading infertility testing laboratory. The company was founded in 1994 by life sciences entrepreneur Craig Sockol. Craig had successfully sold a business that developed and manufactured kits for clinical lab testing and was deciding what to do next. When he and his wife experienced recurrent pregnancy loss (RPL)—and knowing a bit about the testing business—he sought help for their problems. They saw many physicians before finding one at Harvard Medical who had developed a new test for RPL.